Regional vulnerability of mesencephalic dopaminergic neurons prone to degenerate in Parkinson's disease: a post-mortem study in human control subjects.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Neurobiology of Disease

• Publication date

  2006-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.NBD.2006.04.002PMID 16753304
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nucleolar protein B23 has molecular chaperone activities

  2008cited by this paper
• Transcriptional analysis of multiple brain regions in Parkinson's disease supports the involvement of specific protein processing, energy metabolism, and signaling pathways, and suggests novel disease mechanisms

  2005cited by this paper
• Gene expression profiling of rat midbrain dopamine neurons: implications for selective vulnerability in parkinsonism.

  2005cited by this paper
• Neuregulin-1 increases the proliferation of neuronal progenitors from embryonic neural stem cells.

  2005cited by this paper
• Nucleophosmin/B23, a nuclear PI(3,4,5)P(3) receptor, mediates the antiapoptotic actions of NGF by inhibiting CAD.

  2005cited by this paper
• Expression profiling of substantia nigra in Parkinson disease, progressive supranuclear palsy, and frontotemporal dementia with parkinsonism.

  2005cited by this paper
• Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection.

  2005cited by this paper
• Gene expression profiles derived from single cells in human postmortem brain.

  2004cited by this paper
• Neuregulin-1 (NRG-1) mRNA and protein in the adult human brain.

  2004cited by this paper
• Neuregulin-1 is neuroprotective and attenuates inflammatory responses induced by ischemic stroke.

  2004cited by this paper
• Stabilization of the E3 Ubiquitin Ligase Nrdp1 by the Deubiquitinating Enzyme USP8

  2004cited by this paper
• Supranigral injection of neuregulin1-beta induces striatal dopamine overflow.

  2004cited by this paper
• Supranigral injection of neuregulin1-β induces striatal dopamine overflow

  2004cited by this paper
• Receptor tyrosine kinase ErbB4 modulates neuroblast migration and placement in the adult forebrain

  2004cited by this paper
• Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia

  2004cited by this paper
• Dysregulation of Gene Expression in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Lesioned Mouse Substantia Nigra

  2004cited by this paper
• Neuregulin-1beta induces neurite extension and arborization in cultured hippocampal neurons.

  2004cited by this paper
• Neuregulin-1β induces neurite extension and arborization in cultured hippocampal neurons

  2004cited by this paper
• Short- and long-range attraction of cortical GABAergic interneurons by neuregulin-1.

  2004cited by this paper
• Neurotrophic and neuroprotective effects of the neuregulin glial growth factor‐2 on dopaminergic neurons in rat primary midbrain cultures

  2004cited by this paper
• Gene expression profiling of parkinsonian substantia nigra pars compacta; alterations in ubiquitin-proteasome, heat shock protein, iron and oxidative stress regulated proteins, cell adhesion/cellular matrix and vesicle trafficking genes

  2004cited by this paper
• Axonal Neuregulin-1 Regulates Myelin Sheath Thickness

  2004cited by this paper
• Downregulation and increased turnover of beta-amyloid precursor protein in skeletal muscle cultures by neuregulin-1.

  2003cited by this paper
• Profiling genes related to mitochondrial function in mice treated with N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

  2003cited by this paper
• Distinctive Roles of PHAP Proteins and Prothymosin-α in a Death Regulatory Pathway

  2003cited by this paper
• Neuregulin promotes autophagic cell death of prostate cancer cells

  2003cited by this paper
• Distinctive roles of PHAP proteins and prothymosin-alpha in a death regulatory pathway.

  2003cited by this paper
• Using cDNA microarray to assess Parkinson's disease models and the effects of neuroprotective drugs.

  2003cited by this paper
• Pharmacophore model for novel inhibitors of ubiquitin isopeptidases that induce p53-independent cell death.

  2002cited by this paper
• The UCH-L1 gene encodes two opposing enzymatic activities that affect-synuclein degradation and Park

  2002cited by this paper
• Neuregulin 1 and susceptibility to schizophrenia.

  2002cited by this paper
• Increased expression and redistribution of the antiapoptotic molecule Bcl-xL in Parkinson's disease.

  2002cited by this paper
• Processing of β-Amyloid Precursor-like Protein-1 and -2 by γ-Secretase Regulates Transcription*

  2002cited by this paper
• The KLHL1-antisense transcript ( KLHL1AS) is evolutionarily conserved.

  2002cited by this paper
• Importins fulfil a dual function as nuclear import receptors and cytoplasmic chaperones for exposed basic domains

  2002cited by this paper
• Processing of beta-amyloid precursor-like protein-1 and -2 by gamma-secretase regulates transcription.

  2002cited by this paper
• The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility.

  2002cited by this paper
• A novel function for the 90 kDa heat-shock protein (Hsp90): facilitating nuclear export of 60 S ribosomal subunits.

  2002cited by this paper
• Identification and comparative analysis of differentially expressed proteins in rat striatum following 6‐hydroxydopamine lesions of the nigrostriatal pathway: up‐regulation of amyloid precursor‐like protein 2 expression

  2002cited by this paper
• Cloning and Characterization of Mouse UBPy, a Deubiquitinating Enzyme That Interacts with the Ras Guanine Nucleotide Exchange Factor CDC25Mm/Ras-GRF1*

  2001cited by this paper
• Tumor suppression and potentiation by manipulation of pp32 expression

  2001cited by this paper
• NAIP protects the nigrostriatal dopamine pathway in an intrastriatal 6‐OHDA rat model of Parkinson's disease

  2001cited by this paper
• Proteasomal function is impaired in substantia nigra in Parkinson's disease.

  2001cited by this paper
• Microarrays: applications in neuroscience to disease, development, and repair.

  2001cited by this paper
• Heat-shock protein 70 can replace viral protein R of HIV-1 during nuclear import of the viral preintegration complex.

  2000cited by this paper
• A Deubiquitinating Enzyme UBPY Interacts with the Src Homology 3 Domain of Hrs-binding Protein via a Novel Binding Motif PX(V/I)(D/N)RXXKP*

  2000cited by this paper
• The ubiquitin system

  2000cited by this paper
• Mice with Combined Gene Knock-Outs Reveal Essential and Partially Redundant Functions of Amyloid Precursor Protein Family Members

  2000cited by this paper
• Erratum: The SCA8 transcript is an antisense RNA to a brain-specific transcript encoding a novel actin-binding protein (KLHL1) (Human Molecular Genetics (2000) vol. 9 (1543-1551))

  2000cited by this paper
• Roles of molecular chaperones in cytoplasmic protein folding.

  2000cited by this paper
• The SCA8 transcript is an antisense RNA to a brain-specific transcript encoding a novel actin-binding protein (KLHL1).

  2000cited by this paper
• The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry.

  1999cited by this paper
• Characterization of Mayven, a novel actin-binding protein predominantly expressed in brain.

  1999cited by this paper
• An untranslated CTG expansion causes a novel form of spinocerebellar ataxia (SCA8)

  1999cited by this paper
• Failure of spinal cord oligodendrocyte development in mice lacking neuregulin.

  1999cited by this paper
• Identification of Sequences Required for Inhibition of Oncogene-mediated Transformation by pp32*

  1999cited by this paper
• NRP/B, a Novel Nuclear Matrix Protein, Associates With p110RB and Is Involved in Neuronal Differentiation

  1998cited by this paper
• Expression analysis and chromosomal mapping of a novel human gene, APRIL, encoding an acidic protein rich in leucines.

  1998cited by this paper
• Immunohistochemical and in situ analysis of amyloid precursor-like protein-1 and amyloid precursor-like protein-2 expression in Alzheimer disease and aged control brains.

  1998cited by this paper
• The ubiquitin system.

  1998cited by this paper
• Understanding cell death in parkinson's disease

  1998cited by this paper
• UBPY: a growth‐regulated human ubiquitin isopeptidase

  1998cited by this paper
• The cerebellar leucine-rich acidic nuclear protein interacts with ataxin-1

  1997cited by this paper
• Identification and characterization of nucleophosmin/B23/numatrin which binds the anti-oncogenic transcription factor IRF-1 and manifests oncogenic activity

  1997cited by this paper
• Identification of a new member (ZNF183) of the Ring finger gene family in Xq24-25.

  1997cited by this paper
• Structure of pp32, an acidic nuclear protein which inhibits oncogene-induced formation of transformed foci.

  1996cited by this paper
• Midbrain dopaminergic neurons in the mouse that contain calbindin-D28k exhibit reduced vulnerability to MPTP-induced neurodegeneration.

  1996cited by this paper
• In vivo nuclear transport kinetics in Saccharomyces cerevisiae: a role for heat shock protein 70 during targeting and translocation

  1996cited by this paper
• Subsets of midbrain dopaminergic neurons in monkeys are distinguished by different levels of mRNA for the dopamine transporter: Comparison with the mRNA for the D2 receptor, tyrosine hydroxylase and calbindin immunoreactivity

  1995cited by this paper
• Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1.

  1994cited by this paper
• Chronic MPTP treatment reproduces in baboons the differential vulnerability of mesencephalic dopaminergic neurons observed in Parkinson's disease.

  1994cited by this paper
• Midbrain Dopaminergic Cell Loss in Parkinson's Disease and MPTP‐Induced Parkinsonism: Sparing of Calbindin‐D25k—Containing Cells a

  1992cited by this paper
• Dopaminergic neurons expressing calbindin in normal and parkinsonian monkeys.

  1991cited by this paper
• Specific reduction of calcium-binding protein (28-kilodalton calbindin-D) gene expression in aging and neurodegenerative diseases.

  1990cited by this paper
• Major nucleolar proteins shuttle between nucleus and cytoplasm.

  1989cited by this paper
• Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease

  1988cited by this paper

• Calbindin Stratifies Midbrain Dopaminergic Neurons Governing Distinct Aspects of Locomotion

  2025cites this paper
• Application of single-cell sequencing technology and its clinical implications in Parkinson’s disease and Alzheimer’s disease: a narrative review

  2025cites this paper
• Transcriptomics of Human Brain Tissue in Parkinson’s Disease: a Comparison of Bulk and Single-cell RNA Sequencing

  2024cites this paper
• Single-cell sequencing insights into the transcriptional landscape of Parkinson's disease.

  2024cites this paper
• A network-based systems genetics framework identifies pathobiology and drug repurposing in Parkinson’s disease

  2024cites this paper
• Modeling Lewy body disease with SNCA triplication iPSC-derived cortical organoids and identifying therapeutic drugs

  2024cites this paper
• Retromer-dependent lysosomal stress in Parkinson's disease

  2024cites this paper
• Longitudinal in vivo metabolic labeling reveals tissue-specific mitochondrial proteome turnover rates and proteins selectively altered by parkin deficiency

  2023cites this paper
• Single-cell genomic profiling of human dopamine neurons identifies a population that selectively degenerates in Parkinson’s disease

  2022cites this paper
• A molecular census of midbrain dopaminergic neurons in Parkinson’s disease

  2021cites this paper
• rAAV8-mediated in vivo reprogramming of striatal astrocytes into neurons as a potential therapeutic strategy for neurodegenerative diseases

  2018cites this paper
• Chronic MPTP administration regimen in monkeys: a model of dopaminergic and non-dopaminergic cell loss in Parkinson’s disease

  2018cites this paper
• miR‐365 promotes diabetic retinopathy through inhibiting Timp3 and increasing oxidative stress

  2017cites this paper
• Differential expression of calbindin in nigral dopaminergic neurons in two mice strains with differential susceptibility to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

  2016cites this paper
• Calbindin content and differential vulnerability of midbrain efferent dopaminergic neurons in macaques

  2014cites this paper
• Using the natural resistance of motor neuron subpopulations to identify therapeutic targets in amyotrophic lateral sclerosis

  2014cites this paper
• Mitochondrion- and Endoplasmic Reticulum-Induced SK Channel Dysregulation as a Potential Origin of the Selective Neurodegeneration in Parkinson’s Disease

  2012cites this paper
• Systems Biology of Parkinson's Disease

  2012cites this paper
• Current status and future directions of gene expression profiling in Parkinson's disease.

  2012cites this paper
• Gene expression in the Parkinson's disease brain

  2012cites this paper
• Gene expression for HIV-associated dementia and HIV encephalitis in microdissected neurons 1: preliminary analysis

  2011cites this paper
• The importance of molecular histology to study glial influence on neurodegenerative disorders. Focus on recent developed single cell laser microdissection

  2009cites this paper
• Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology.

  2009cites this paper
• Genomic aspects of sporadic Parkinson's disease.

  2008cites this paper
• Neurophysiologic study of central pain in patients with Parkinson disease

  2007cites this paper
• Death in the substantia nigra: a motor tragedy

  2007cites this paper
• Readministration of adenoviral gene delivery to dopamine neurons

  2007cites this paper